Dr. Shelita Dattani is the Director, Practice Development and Knowledge Translation, at the Canadian Pharmacists Association.
Sheli received her bachelor of science in pharmacy from Northeastern University and her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill. She has worked in numerous practice settings including hospital, community, academic, and industry in the US and Canada where she has led dynamic teams towards excellence in effective and safe best medication practice. Sheli has also held teaching appointments at the University of Ottawa and has precepted students at the University of Waterloo and University of Toronto and has a passion for teaching future leaders in the profession. She has authored several articles and book chapters and has presented in various capacities at local and national conferences.
For the past three years, Sheli has provided leadership towards a national vision for evidence informed practice development to support the advancement of pharmacists practice in Canada. Within her portfolio, she is also responsible for leading the transfer and mobilization of pharmacy practice research knowledge to the pharmacy community to support practice advancement and enhance patient care. Sheli is also responsible for providing overall portfolio leadership in the professional and research streams of the national Canadian Pharmacists Conference.
Sheli maintains a part-time practice in community pharmacy and remote hospital telepharmacy. She is a member of several professional organizations and holds an active pharmacist license in the province of Ontario
Sheli has a strong interest and passion for advancement of the pharmacy profession in the provision of excellence in patient care.
Pharmacists, as the medication experts on a patient’s health care team, provide valuable expertise to patients and other health care providers in the care of patients using cannabis for medical purposes. This presentation, through an overview and case illustration, will discuss the role of pharmacist as medication management stewards as it applies to their role in providing care to patients using cannabis for either medical or non-medical use , guiding patients and providers in a shared decision model of patient care and safety
By the end of this presentation the participant will be able to:
Apply evidence with respect to cannabis as an adjunctive therapeutic modality for certain conditions
Utilize information related to adverse effects, pharmacokinetics and drug interactions with cannabis in the development of a patient care, assessment and monitoring plan
Explain the broader role of pharmacists in supporting patient care related to cannabinoid use